Avid Bioservices, Inc. CDMOP Cash Flow

Avid bioservices, inc. (CDMOP)

CashFlow / Quarterly

Jan'20	Oct'19	Jul'19	Apr'19	Jan'19	Oct'18	Jul'18	Apr'18	Jan'18	Oct'17	Jul'17	Apr'17	Jan'17	Oct'16	Jul'16	Apr'16	Jan'16	Oct'15	Jul'15	Apr'15	Jan'15	Oct'14	Jul'14	Apr'14	Jan'14	Oct'13	Jul'13	Apr'13	Jan'13	Oct'12	Jul'12	Apr'12	Jan'12	Oct'11	Jul'11	Apr'11	Jan'11	Oct'10	Jul'10
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss
-2,104	-430	-3,164	336	-1,139	-1,451	-1,961	3,020	-11,004	-12,624	-1,205	-5,272	-7,774	-4,056	-11,057	-11,884	-16,847	-13,198	-13,723	-12,135	-12,994	-12,100	-13,129	-10,248	-9,724	-7,790	-7,600	-8,449	-4,914	-8,753	-7,664	-10,882	-11,090	-12,055	-8,092	-10,014	-8,929	-7,513	-7,695
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization
809	741	726	740	681	683	642	617	645	658	642	613	631	606	613	614	464	223	234	238	261	265	277	249	244	236	257	281	280	266	260	244	238	223	203	-	-	-	-
Stock-based compensation
595	651	603	515	458	325	297	332	412	309	485	772	869	885	837	1,158	1,283	1,274	1,183	1,422	1,616	1,888	1,776	1,293	1,601	1,720	1,593	1,115	1,029	629	662	331	759	795	884	839	711	644	643
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	174	157	138
Amortization of discount on notes payable and debt issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	1	11	21	31	43	53	108
Common stock issued for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	717	239
Changes in operating assets and liabilities:
Accounts receivable
2,729	-801	849	-511	3,688	1,246	-803	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Trade and other receivables
-	-	-	-	-	-	-	-	4,459	-4,376	142	-	-183	-1,471	4,678	-5,740	5,695	1,099	-2,008	-2,471	2,923	1,970	59	-1,450	1,394	-884	610	-321	-403	-49	82	1,560	-887	-11	302	686	447	-1,230	189
Contract assets
1	521	1,262	415	-1,180	317	1,887	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract assets
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Government contract receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	93	-	-	-	-
Government contract receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	44	165	-223
Inventory
1,756	-222	1,474	-2,103	-1,076	568	910	1,911	-2,300	-7,717	-8,864	-730	7,905	650	9,088	997	2,635	2,097	3,103	1,206	769	-619	468	306	579	-1,034	1,340	-296	2,839	318	-2,133	-4,213	434	1,303	803	-1,368	-361	1,137	-1,569
Prepaid expenses
-	-	-	-	-	-	-	-	-312	345	-45	-	36	476	-116	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets of discontinued operations
-	-	-	-	-	-	-	-	-	-	27	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-current assets
-	-	-	-	-	-	-	-	0	0	-9	-	-77	-78	-78	751	33	-444	-15	-13	-14	-14	29	-	-	-	0	-	-	-	-	-1,537	1	649	98	-66	0	-70	129
Prepaid expenses and other assets
-163	149	68	142	-207	246	-153	-	-	-	-	-	-	-	-	-	351	943	-303	-	-255	306	-536	369	506	-91	-74	-169	173	2	-92	127	-114	-279	108	365	206	-538	62
Other non-current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	201	200	-30
Accounts payable
577	324	-410	1,132	113	-271	1,151	-96	251	-1,143	-283	-2,651	-4,041	2,666	222	768	1,658	-3,096	-2,851	1,408	1,386	-2,034	2,518	585	-449	134	-661	1,192	-1,567	-937	621	-482	-426	1,466	-1,159	1,410	-268	0	-534
Accrued clinical trial and related fees
-	-	-	-	-	-	-	-	-	-	-	-	-512	-2,938	-1,017	619	837	2,032	196	793	580	650	-2,546	3,075	329	421	-322	-548	-80	-351	-202	-931	820	-564	494	387	-554	1,200	-49
Accrued payroll and related expenses
-375	130	-310	991	720	-201	-534	-220	-484	-581	-1,206	556	357	1,627	-2,168	1,324	367	1,036	-1,512	890	244	818	-1,183	528	157	-119	-311	633	555	-514	440	370	575	-9	77	-59	433	-692	150
Contract liabilities
4,156	4,095	3,453	31	-2,687	-687	-2,028	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract liabilities
-	-	-	-	-	-	-	-	-	-	-17,762	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	8,387	-3,551	11,501	-5,388	5,730	1,397	1,661	878	2,140	-1,058	-863	912	861	-696	-7	-890	-1,073	86	2,328	937	462	-2,086	-1,550	1,277	1,862	-734	1,438
Deferred government contract revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12	-31
Customer deposits
-	-	-	-	-	-	-	-	-	-	-	-	-718	5,197	-2,481	1,779	7,498	5,336	-1,764	3,052	762	1,323	466	-2,886	988	-870	469	1,330	-1,771	-1,724	5,359	2,402	760	1,414	-1,470	-892	-674	1,134	-427
Other liabilities
-	-	287	-	-	-	-579	722	115	200	-28	394	-325	343	-819	441	380	47	183	-53	-78	-29	108	-722	143	-242	357	88	-134	-205	275	-33	6	-118	83	162	54	50	106
Assets and liabilities of discontinued operations
0	0	0	-125	-291	-1,539	-2,595	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities of discontinued operations
-	-	-	-	-	-	-	-	-	-	-1,937	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent, less current portion
-	-	-	-	-	-	-	-	-107	291	281	-	-22	-67	19	-72	-67	-64	-62	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	49	408	-47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other long-term liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	118	-69	23	-	138	-21	-37	482	-31	-27	-166	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7,398	-9,344	-17,232	-2,408	-9,456	-11,512	-12,643	-	-	-	-8,124	-	-	-	-	-	-	-	-	-	-	-	-
Other long-term liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29	-161	255
Net cash provided by (used in) operating activities
-636	5,884	-2,468	5,648	-3,082	-6,713	-7,448	2,109	-8,633	-7,258	-12,210	-11,553	-10,829	1,135	-17,922	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-9,557	-101	-	-8,490	-9,381	-9,271	-6,998	-6,730	-5,663	-7,071
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
2,040	947	38	254	802	254	192	1,649	335	1,406	403	983	1,578	791	275	969	3,375	3,435	1,099	4,242	2,234	1,222	1,349	-	-	-	27	-	-	-	-	-	-	-	-	-	-	-	-
Property and equipment acquisitions
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-377	-119	-190	-	-418	-322	-363	-247	-86	-65	-514
Decrease in other assets
-	-	-	-	-	-	-	-	-	-	-	-363	-205	-100	100	-	-	-	-395	541	-98	-525	-516	545	182	817	223	-157	-146	26	175	-349	-226	223	-31	-	-	-	-
Proceeds from sale of research and development assets
-	0	0	-	-	3,000	3,000	3,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,408	-3,371	-704	-4,783	-2,136	-697	-833	-	-	-	-250	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by investing activities
-2,040	-947	-38	-208	-802	2,746	2,808	1,351	-335	-1,406	-403	-620	-1,373	-691	-375	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-145	-365	-	-192	-545	-332	-311	-287	-265	-484
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of stock options
485	173	258	90	30	144	1,014	354	286	78	34	31	0	0	0	0	6	39	93	21	128	37	112	695	120	45	84	19	43	28	6	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net of issuance costs
-	-	-	-	-	-	-	21,494	0	0	4,193	18,846	5,823	3,666	2,115	1,697	7,300	26,307	9,891	12,030	2,992	3,792	421	-	-	-	14,706	-	-	-	-	-	-	-	-	-	14,336	5,612	6,482
Proceeds from issuance of common stock, net of issuance costs of $513,000, $1,504,000, and $1,232,000, respectively
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,356	8,571	16,158	1,437	6,989	10,740	11,863	3,587	-	-	-	-
Proceeds from issuance of preferred stock, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,636	49	34	9,484	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid on preferred stock
1,082	1,081	1,081	1,081	1,082	1,081	1,081	1,081	1,082	1,081	1,081	1,081	1,082	1,081	1,035	1,036	1,035	1,035	1,033	1,034	774	773	771	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on finance lease
0	0	78	-	0	0	74	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on capital lease
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	333	481	519	457	519	399	625
Principal payments on capital leases
-	-	-	-	-	-	-	0	26	78	76	74	65	0	0	-	-	-	-	0	4	5	4	4	4	4	20	20	19	20	19	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,271	25,704	8,951	19,954	2,391	3,392	9,242	-	-	-	14,770	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-597	-721	-901	-847	-1,052	-823	-141	20,867	-821	-865	3,070	17,994	4,675	4,416	1,080	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15,154	1,424	-	10,388	11,441	3,068	6,316	13,817	5,213	5,857
Net decrease in cash, cash equivalents and restricted cash
-3,273	4,216	-3,407	-	-4,936	-4,790	-4,781	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in cash, cash equivalents and restricted cash
-	-	-	-	-	-	-	24,327	-9,789	-9,529	-9,543	5,821	-7,527	4,860	-17,217	-6,058	-4,535	12,989	-8,985	12,763	-9,201	-8,817	-4,234	14,313	18,734	2,843	6,396	8,949	1,812	5,452	958	-1,728	1,706	1,515	-6,535	-993	6,800	-715	-1,698
SUPPLEMENTAL DISCLOSURES OF NON-CASH ACTIVITIES:
Unpaid purchases of property and equipment
-1,371	344	1,516	304	-420	372	62	-	-	-609	748	238	165	-189	444	-	-	157	2,306	2,163	1,588	794	128	-30	-43	77	0	9	11	-38	38	34	-59	0	72	-87	91	290	6
Property and equipment acquired under finance lease
0	0	0	0	0	0	245	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	180
Lease incentives
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-270	0	-222	592	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-